We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
(Approval lapsed) Carbidopa and levodopa tablets, USP 25 mg/100mg (ScieGen)
Section 19A approved medicine
(Approval lapsed) Carbidopa and levodopa tablets, USP 25 mg/100mg (ScieGen)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 730 109 715 16
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
KINSON levodopa 100 mg with carbidopa (as monohydrate) 25 mg tablet bottle - ARTG 49481
Indication(s)
The treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. Carbidopa and levodopa tablets frequently are helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with Parkinson's disease and syndrome.
Images
